| Name | Elmora Pharmacy Inc |
|---|---|
| Organization Name | Elmora Pharmacy, Inc. |
| Location | 162 Elmora Ave, Elizabeth, New Jersey 07202 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (908) 352-8808 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
With support from the National Institutes of Health's Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, scientists are developing powerful new devices and technologies to monitor and regulate brain activity.
Senate Majority Leader Sen. Harry Reid's health reform bill fulfills the promise that more than 132 million Americans with family dental coverage can keep their current dental plan without disrupting established dentist-patient relationships, according to the National Association of Dental Plans.
Outcomes Pharmaceutical Health Care® has announced it has detected over one million drug therapy problems through its Targeted Intervention Program (TIP®).
Eisai Europe Ltd. today announced that it has submitted a marketing authorization application to the European Medicines Agency (EMA) for approval of eribulin mesylate, also known as 'E7389', for the treatment of locally advanced or metastatic breast cancer in Europe. Eribulin mesylate, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai. Regulatory applications for eribulin mesylate have also been submitted in the United States and Japan.
Exactech Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has committed more than $100,000 to fund research and residency enhancement grants and contribute to post-graduate fellowship grants through OREF's Clinician Development Program (CDP).
› Verified 3 days ago
| NPI Number | 1245216597 |
| Organization Name | ELMORA PHARMACY, INC. |
| Doing Business As | ELMORA HEALTHCARE |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 162 Elmora Ave, Elizabeth, NJ 07202 |
| Phone Number | 908-352-8808 |
News Archive
With support from the National Institutes of Health's Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, scientists are developing powerful new devices and technologies to monitor and regulate brain activity.
Senate Majority Leader Sen. Harry Reid's health reform bill fulfills the promise that more than 132 million Americans with family dental coverage can keep their current dental plan without disrupting established dentist-patient relationships, according to the National Association of Dental Plans.
Outcomes Pharmaceutical Health Care® has announced it has detected over one million drug therapy problems through its Targeted Intervention Program (TIP®).
Eisai Europe Ltd. today announced that it has submitted a marketing authorization application to the European Medicines Agency (EMA) for approval of eribulin mesylate, also known as 'E7389', for the treatment of locally advanced or metastatic breast cancer in Europe. Eribulin mesylate, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai. Regulatory applications for eribulin mesylate have also been submitted in the United States and Japan.
Exactech Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has committed more than $100,000 to fund research and residency enhancement grants and contribute to post-graduate fellowship grants through OREF's Clinician Development Program (CDP).
› Verified 3 days ago
| NPI Number | 1558880252 |
| Organization Name | ELMORA PHARMACY, INC. |
| Doing Business As | ELMORA HEALTHCARE |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 162 Elmora Ave, Elizabeth, NJ 07202 |
| Phone Number | 908-352-8808 |
News Archive
With support from the National Institutes of Health's Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, scientists are developing powerful new devices and technologies to monitor and regulate brain activity.
Senate Majority Leader Sen. Harry Reid's health reform bill fulfills the promise that more than 132 million Americans with family dental coverage can keep their current dental plan without disrupting established dentist-patient relationships, according to the National Association of Dental Plans.
Outcomes Pharmaceutical Health Care® has announced it has detected over one million drug therapy problems through its Targeted Intervention Program (TIP®).
Eisai Europe Ltd. today announced that it has submitted a marketing authorization application to the European Medicines Agency (EMA) for approval of eribulin mesylate, also known as 'E7389', for the treatment of locally advanced or metastatic breast cancer in Europe. Eribulin mesylate, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai. Regulatory applications for eribulin mesylate have also been submitted in the United States and Japan.
Exactech Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has committed more than $100,000 to fund research and residency enhancement grants and contribute to post-graduate fellowship grants through OREF's Clinician Development Program (CDP).
› Verified 3 days ago
News Archive
With support from the National Institutes of Health's Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, scientists are developing powerful new devices and technologies to monitor and regulate brain activity.
Senate Majority Leader Sen. Harry Reid's health reform bill fulfills the promise that more than 132 million Americans with family dental coverage can keep their current dental plan without disrupting established dentist-patient relationships, according to the National Association of Dental Plans.
Outcomes Pharmaceutical Health Care® has announced it has detected over one million drug therapy problems through its Targeted Intervention Program (TIP®).
Eisai Europe Ltd. today announced that it has submitted a marketing authorization application to the European Medicines Agency (EMA) for approval of eribulin mesylate, also known as 'E7389', for the treatment of locally advanced or metastatic breast cancer in Europe. Eribulin mesylate, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai. Regulatory applications for eribulin mesylate have also been submitted in the United States and Japan.
Exactech Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has committed more than $100,000 to fund research and residency enhancement grants and contribute to post-graduate fellowship grants through OREF's Clinician Development Program (CDP).
› Verified 3 days ago
Cherish Drugs Inc Type: Community/Retail Pharmacy Location: 700 E Jersey St, Elizabeth, New Jersey 07201 Phone: (908) 354-2060 | |
Cvs Pharmacy #07613 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 214 Rahway Ave, Elizabeth, New Jersey 07202 Phone: (908) 965-2118 | |
Cvs Pharmacy #00867 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1000 S Elmora Ave, Elizabeth, New Jersey 07202 Phone: (908) 629-1265 | |
Cvs Pharmacy #00955 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 430 Westfield Ave, Elizabeth, New Jersey 07208 Phone: (908) 351-7911 | |
Walgreens #6748 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 401 Rahway Ave, Elizabeth, New Jersey 07202 Phone: (908) 527-9203 |